SRZN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 45.18%

Insider Buying (Last 12 Months): $19,981,053.30

Insider Selling (Last 12 Months): $35,156.88

Surrozen Insider Trading History Chart

Surrozen Share Price & Price History

^$18.23

▲ +2.48 (15.75%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

Surrozen Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/13/2025	Group Gp Lp Column III	Major Shareholder	Buy	315,457	$12.65	$3,990,531.05	962,718
11/13/2025	Tim Kutzkey	Director	Buy	315,457	$12.65	$3,990,531.05	962,718
3/26/2025	Group Gp Lp Column III	Major Shareholder	Buy	1,034,482	$11.60	$11,999,991.20	795,411
1/3/2025	Charles O Williams	CFO	Sell	1,181	$17.37	$20,513.97	8,982
1/3/2025	Yang Li	VP	Sell	843	$17.37	$14,642.91	13,345
4/4/2024	Tim Kutzkey	Director	Buy	193,548	$15.50	$2,999,994.00	332,885

SEC Filings (Institutional Ownership Changes) for Surrozen (NASDAQ:SRZN)

66.57% of Surrozen stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Surrozen Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/17/2025	Woodline Partners LP	48,193	$0.62M	0.0%	N/A	0.562%
11/17/2025	Millennium Management LLC	109,769	$1.41M	0.0%	N/A	1.281%
11/17/2025	Citadel Advisors LLC	13,875	$0.18M	0.0%	+32.8%	0.162%
11/14/2025	Schonfeld Strategic Advisors LLC	69,024	$0.89M	0.0%	N/A	0.805%
11/14/2025	Acuta Capital Partners LLC	178,415	$2.30M	2.4%	+5.0%	2.082%
11/7/2025	Vanguard Group Inc.	266,418	$3.43M	0.0%	+21.7%	3.109%
8/15/2025	Braidwell LP	140,000	$1.25M	0.0%	N/A	1.636%
8/14/2025	Armistice Capital LLC	60,000	$0.54M	0.0%	N/A	0.701%
8/14/2025	Stempoint Capital LP	686,539	$6.14M	2.0%	+185.1%	8.018%
8/13/2025	Stonepine Capital Management LLC	306,029	$2.74M	2.7%	+7.1%	3.575%
8/8/2025	Geode Capital Management LLC	30,963	$0.28M	0.0%	+22.6%	0.362%
5/16/2025	5AM Venture Management LLC	310,000	$3.62M	1.4%	N/A	9.448%
5/16/2025	Adage Capital Partners GP L.L.C.	88,653	$1.03M	0.0%	+37.1%	2.702%
5/15/2025	RA Capital Management L.P.	679,130	$7.92M	0.1%	+140.3%	20.699%
5/15/2025	Nantahala Capital Management LLC	229,527	$2.68M	0.1%	+17.1%	6.996%
5/15/2025	Driehaus Capital Management LLC	204,934	$2.39M	0.0%	N/A	6.246%
5/15/2025	Heights Capital Management Inc.	44,978	$0.52M	0.3%	N/A	1.371%
5/14/2025	Stonepine Capital Management LLC	285,782	$3.33M	3.2%	+108.3%	8.710%
5/12/2025	Vivo Capital LLC	260,000	$3.03M	0.4%	N/A	7.924%
2/17/2025	Trustees of Columbia University in the City of New York	47,930	$0.69M	0.1%	N/A	1.475%
2/17/2025	Stonepine Capital Management LLC	137,200	$1.97M	1.6%	+24.7%	4.222%
2/17/2025	Stempoint Capital LP	350,573	$5.03M	1.3%	+91.7%	10.787%
2/17/2025	Alyeska Investment Group L.P.	10,188	$0.15M	0.0%	-50.0%	0.313%
2/14/2025	Nantahala Capital Management LLC	196,023	$2.81M	0.1%	+4.7%	6.031%
2/14/2025	Adage Capital Partners GP L.L.C.	64,653	$0.93M	0.0%	N/A	1.989%
2/12/2025	Geode Capital Management LLC	22,391	$0.32M	0.0%	+26.1%	0.689%
2/5/2025	Regents of The University of California	133,207	$1.91M	0.6%	N/A	4.099%
11/14/2024	Stonepine Capital Management LLC	110,000	$1.32M	0.8%	+66.5%	3.427%
8/21/2024	Stonepine Capital Management LLC	66,084	$0.72M	0.7%	N/A	2.066%
8/20/2024	Nantahala Capital Management LLC	187,206	$2.05M	0.1%	N/A	5.852%
8/15/2024	CVI Holdings LLC	64,905	$0.71M	0.6%	N/A	2.029%
8/15/2024	Armistice Capital LLC	190,000	$2.08M	0.0%	N/A	5.939%
2/15/2024	Board of Trustees of The Leland Stanford Junior University	52,131	$0.49M	0.0%	-93.3%	2.557%
2/9/2024	Column Group LLC	627,651	$5.90M	3.9%	-93.3%	30.767%
12/1/2023	Euclidean Capital LLC	1,315,463	$0.65M	0.1%	+63.8%	64.483%
10/23/2023	BML Capital Management LLC	89,271	$44K	0.0%	-93.9%	0.292%
7/24/2023	Column Group LLC	9,414,795	$5.18M	2.0%	+1.8%	31.299%
7/24/2023	BML Capital Management LLC	1,459,084	$0.80M	0.7%	-2.3%	4.851%
4/14/2023	BML Capital Management LLC	1,494,037	$0.90M	0.8%	N/A	4.967%
11/15/2022	Empery Asset Management LP	215,942	$0.44M	2.6%	-16.2%	0.615%
11/15/2022	Board of Trustees of The Leland Stanford Junior University	781,960	$1.58M	0.1%	+3,102.9%	2.227%
8/13/2022	Column Group LLC	9,248,129	$27.75M	5.9%	-1.8%	26.328%
8/12/2022	Board of Trustees of The Leland Stanford Junior University	24,414	$73K	0.0%	-97.0%	0.070%
5/17/2022	Empery Asset Management LP	333,965	$1.01M	4.7%	-42.5%	0.951%
2/15/2022	Laurion Capital Management LP	520,000	$3.35M	0.0%	+40.5%	1.485%
2/15/2022	Consonance Capital Management LP	3,497,500	$22.36M	14.6%	+249.8%	9.987%
2/14/2022	Perceptive Advisors LLC	413,446	$2.66M	0.0%	-17.3%	1.181%
2/11/2022	Column Group LLC	9,414,795	$60.63M	8.2%	+1.8%	26.884%
2/9/2022	Wolverine Asset Management LLC	9,172	$59K	0.0%	+466.5%	0.026%
2/7/2022	Monashee Investment Management LLC	350,000	$2.25M	0.6%	-30.0%	0.999%
12/29/2021	Hudson Bay Capital Management LP	300,000	$2.11M	0.0%	N/A	2.514%
12/3/2021	Perceptive Advisors LLC	500,000	$3.54M	0.1%	N/A	4.190%
11/16/2021	Laurion Capital Management LP	370,000	$2.62M	0.0%	N/A	3.100%
11/16/2021	Bridger Management LLC	700,001	$4.19M	0.5%	N/A	5.866%
11/16/2021	Boxer Capital LLC	200,000	$1.42M	0.0%	N/A	1.676%
11/15/2021	Trustees of Columbia University in the City of New York	718,950	$5.09M	7.8%	N/A	6.024%
11/15/2021	Harvard Management Co. Inc.	826,852	$5.85M	0.3%	N/A	6.929%
11/15/2021	Highbridge Capital Management LLC	11,701	$83K	0.0%	N/A	0.098%
11/15/2021	Jasper Ridge Partners L.P.	46,838	$0.33M	0.0%	N/A	0.392%
11/12/2021	Board of Trustees of The Leland Stanford Junior University	806,374	$5.71M	0.4%	N/A	6.757%
11/9/2021	BlackRock Inc.	34,959	$0.25M	0.0%	N/A	0.293%
11/9/2021	Monashee Investment Management LLC	500,000	$3.54M	0.7%	N/A	4.191%

Data available starting January 2016

Surrozen, Inc., a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is developing antibody-based therapeutics which targets various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043, a hepatocyte-specific R-spondin mimetic bispecific fusion protein, which is in Phase 1b clinical trial for the treatment of severe liver diseases, including alcohol-associated hepatitis. The company develops SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies. Surrozen, Inc. is based in South San Francisco, California.

Today's Range

Now: $18.23

$15.73

$18.65

50 Day Range

MA: $13.72

$11.56

$18.23

52 Week Range

Now: $18.23

$5.90

$18.65

Volume

204,482 shs

Average Volume

99,124 shs

Market Capitalization

$156.23 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.62

Who are the company insiders with the largest holdings of Surrozen?: Surrozen's top insider investors include:
Group Gp Lp Column III (Major Shareholder)
Tim Kutzkey (Director)
Yang Li (VP)
Charles O Williams (CFO)
Learn More about top insider investors at Surrozen.
Who are the major institutional investors of Surrozen?: Surrozen's top institutional investors include:
Vanguard Group Inc. — 3.11%
Acuta Capital Partners LLC — 2.08%
Millennium Management LLC — 1.28%
Schonfeld Strategic Advisors LLC — 0.81%
Woodline Partners LP — 0.56%
Citadel Advisors LLC — 0.16%
Learn More about top institutional investors of Surrozen stock.
Which institutional investors are buying Surrozen stock?: Within the last quarter, SRZN stock was bought by institutional investors including:
Millennium Management LLC
Schonfeld Strategic Advisors LLC
Woodline Partners LP
Vanguard Group Inc.
Acuta Capital Partners LLC
Citadel Advisors LLC
During the previous year, these company insiders have bought Surrozen stock:
Group Gp Lp Column III (Major Shareholder)
Tim Kutzkey (Director)
Learn More investors buying Surrozen stock.